[go: up one dir, main page]

UA93609C2 - 2-amino-5,6-dihydro-6h-pyrrolo[3, 4-d]pyrimidine derivatives as hsp-90 inhibitors for treating cancer - Google Patents

2-amino-5,6-dihydro-6h-pyrrolo[3, 4-d]pyrimidine derivatives as hsp-90 inhibitors for treating cancer

Info

Publication number
UA93609C2
UA93609C2 UAA200908018A UAA200908018A UA93609C2 UA 93609 C2 UA93609 C2 UA 93609C2 UA A200908018 A UAA200908018 A UA A200908018A UA A200908018 A UAA200908018 A UA A200908018A UA 93609 C2 UA93609 C2 UA 93609C2
Authority
UA
Ukraine
Prior art keywords
hsp
inhibitors
pyrrolo
dihydro
amino
Prior art date
Application number
UAA200908018A
Other languages
Russian (ru)
Inventor
Майкл Джон Беннетт
Люк Реймонд Зегндер
Сача Нинковик
Пей-Пей Кунг
Джерри Джялун Менг
Бювен Гуанг
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of UA93609C2 publication Critical patent/UA93609C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, their synthesis, and their use as HSP-90 inhibitors., (І)
UAA200908018A 2007-02-06 2008-01-25 2-amino-5,6-dihydro-6h-pyrrolo[3, 4-d]pyrimidine derivatives as hsp-90 inhibitors for treating cancer UA93609C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06

Publications (1)

Publication Number Publication Date
UA93609C2 true UA93609C2 (en) 2011-02-25

Family

ID=41790615

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200908018A UA93609C2 (en) 2007-02-06 2008-01-25 2-amino-5,6-dihydro-6h-pyrrolo[3, 4-d]pyrimidine derivatives as hsp-90 inhibitors for treating cancer

Country Status (3)

Country Link
CN (1) CN101663305A (en)
UA (1) UA93609C2 (en)
ZA (1) ZA200906166B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110259C2 (en) * 2011-09-22 2015-12-10 Пфайзер Інк. PYROLOPYRIMIDINE AND PURINE DERIVATIVES
CN102816792B (en) * 2012-08-17 2018-02-02 南京大学 A kind of regulating heat shock protein 70 is expressed, the method and its application of quantity and activity
CN105237533B (en) * 2015-10-26 2017-03-22 中国药科大学 Tetrahydropyridine [4,3-d] miazines Hsp90 inhibitor and medical application thereof
CN108863886A (en) * 2018-08-01 2018-11-23 江苏八巨药业有限公司 It is a kind of to prepare 3-（3- chloropropyl）The method of -4- oxo-pyrrolidine -1- carboxylic acid, ethyl ester
CN118745133B (en) * 2024-06-24 2025-12-26 南京工业大学 A process for synthesizing dichloroaminoaryl ethers

Also Published As

Publication number Publication date
CN101663305A (en) 2010-03-03
ZA200906166B (en) 2010-06-30

Similar Documents

Publication Publication Date Title
MX2009008386A (en) 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer.
WO2008059368A3 (en) Fused 2-amino pyrimidine compounds and their use for the treatment of cancer
MX2008005398A (en) 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer.
ATE542813T1 (en) 6-SUBSTITUTED 2-HETEROCYCLYLAMINOPYRAZINE COMPOUNDS AS CHK-1 INHIBITORS
GEP20115147B (en) Pyrimidine derivatives used as pi-3 kinase inhibitors
MY146111A (en) Acylaminopyrazoles as fgfr inhibitors
WO2006123113A3 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
NO2016021I1 (en) 5-Amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido [2,3-D] pyrimidine derivatives and related compounds for the treatment of cancer
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MY141220A (en) Pyrazole derivatives as inhibitors of receptor tyrosine kinases
TNSN08283A1 (en) Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
PH12012502438A1 (en) Morpholino pyrimidines and their use in therapy
MX2010004263A (en) Inhibitors of c-fms kinase.
GEP20156282B (en) Compounds and compositions as protein kinase inhibitors
MY146420A (en) Pyrido (2, 3-d) pyrimidinone compounds and their use as pi3 inhibitors
SG178591A1 (en) Jak2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
NO20085217L (en) Effective pyrimidine derivatives in the treatment of cancer
JO2848B1 (en) Organic Compounds
SG154435A1 (en) Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
NZ580671A (en) Pyrimidine derivatives
MX2007005694A (en) Novel betulin derivatives, preparation thereof and use thereof.
UA94622C2 (en) Kinase innhibitor
MX2010013682A (en) Tricyclic 2,4-diamin0-l,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders.
MY155719A (en) 2-benzylpyridazinone derivatives as met kinase inhibitors
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer